Leishmaniasis is a vector-borne infectious disease caused by multiple Leishmania (L.)
species with diverse clinical manifestations. There is currently no vaccine against any form …

Leishmaniasis caused by various species of protozoan transmitted by sand fly vectors
occurs as a spectrum of clinical features including cutaneous, mucocutaneous and visceral …

Leishmaniasis occurs as a spectrum of clinical syndromes divided into cutaneous,
mucocutaneous and visceral forms. The epidemiology and clinical features are highly …

Parasitic diseases still constitute a major global health problem affecting billions of people
around the world. These diseases are capable of becoming chronic and result in high …

Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and
visceral. The visceral form is most dangerous and can result in death. Although …

Leishmaniasis is a neglected protozoan disease that mainly affects the tropical as well as
subtropical countries of the world. The primary option to control the disease still relies on …

Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …

Significant advances have been made in the areas of pathogenesis, host defence, and
treatment of leishmaniasis. A number of new vaccine candidates and potential targets of …

Leishmaniasis has several clinical forms: self-healing or chronic cutaneous leishmaniasis or
post-kala-azar dermal leishmaniasis; mucosal leishmaniasis; visceral leishmaniasis (VL) …

Visceral leishmaniasis, caused by Leishmania donovani, L. infantum (syn. Leishmania
chagasi), is a globally widespread disease with a burden of about 400,000 new infections …